Papers - Tasaka Sadatomo
-
Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.
Sakamoto H, Yanagitani N, Manabe R, Tsugitomi R, Ogusu S, Tozuka T, Yoshida H, Amino Y, Ariyasu R, Uchibori K, Kitazono S, Tasaka S, Nishio M
Cancer reports (Hoboken, N.J.) 4 ( 6 ) e1414 2021.12
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Makiguchi T, Tanaka H, Kamata K, Taima K, Kurose A, Tasaka S
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.10
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Tomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, Kageaki Taima, Akira Kurose, Sadatomo Tasaka
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.8
-
本邦で検証が進む新型たばこ関連肺障害
田坂 定智
週刊医学界新聞 ( 第3429号 ) 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients.
Makiguchi T, Tanaka H, Taima K, Tatsuo S, Iida S, Kakeda S, Tasaka S.
JCSM Clin Rep 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients
2021.7
-
特集 内科疾患の診断基準・病型分類・重症度 第1章 呼吸器 急性呼吸窮迫症候群(ARDS)
田坂 定智
内科 127 ( 4 ) 524 - 526 2021.4
-
疾患と検査値の推移 急性呼吸窮迫症候群(ARDS)
田坂 定智
検査と技術 49 ( 4 ) 508 - 514 2021.4
-
6. Diagnosis and Treatment of ARDS
Tasaka Sadatomo
Nihon Naika Gakkai Zasshi 110 ( Suppl ) 107b - 108a 2021.2
-
Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung.
Masamichi Itoga, Hisashi Tanaka, Kageaki Taima, Yoshiko Ishioka, Hiroaki Sakamoto, Shingo Takanashi, Akira Kurose, Sadatomo Tasaka
BMC research notes 14 ( 1 ) 25 - 25 2021.1
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation.
Hisashi Tanaka, Kageaki Taima, Tomonori Makiguchi, Junichi Nakagawa, Takenori Niioka, Sadatomo Tasaka
Cancer communications (London, England) 41 ( 1 ) 83 - 87 2021.1
-
Activity and bioavailability of tepotinib for leptomeningeal metastasis of NSCLC with MET exon 14 skipping mutation
6. Tanaka H, Taima K, Makiguchi T, Nakagawa J, Niioka T, Tasaka S.
Cancer Commun (Lond) 2021.1
-
易感染宿主の肺炎
田坂 定智
臨牀と研究 98 1363 - 1367 2021
-
リウマチ性疾患患者における間質性肺疾患の診断
田坂 定智
リウマチ科 65(1) 20 - 27 2021
-
ARDSの疾患フェノタイプと治療
田坂 定智
ICUとCCU 45(3) 149 - 153 2021
-
加熱式たばこ・電子たばこの肺障害
田坂 定智
臨床リハ 30(10) 1051 - 1055 2021
-
急性呼吸促迫症候群
田坂 定智
呼吸器症候群（第3版）Ⅱ 197 - 201 2021
-
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study.
Dobashi M, Tanaka H, Taima K, Itoga M, Ishioka Y, Shiratori T, Okumura F, Tabe C, Tanaka Y, Morimoto T, Hasegawa Y, Yasugahira H, Okudera K, Takanashi S, Tasaka S
SAGE open medicine 9 20503121211023357 2021
-
Procalcitonin expression in patients with large cell neuroendocrine carcinoma of the lung.
5. Itoga M, Tanaka H, Taima K, Ishioka Y, Sakamoto H, Takanashi S, Kurose A, Tasaka S.
BMC Res Notes 14 ( 25 ) 2021
-
A Phase I/II study of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer.
Tanaka H, Hasegawa Y, Makiguchi T, Okumura F, Tabe C, Shiratori T, Ishioka Y, Itoga M, Taima K, Yokouchi J, Hatayama Y, Aoki M, Tasaka S.
Clin Lung Cancer 22(1) 42 - 48 2021